Shanghai HeartCare Medical Technology Corporation Limited (HKG:6609)

Market Cap	2.22B +84.8%
Revenue (ttm)	454.34M +46.9%
Net Income	92.74M
EPS	2.45
Shares Out	37.86M
PE Ratio	24.00
Forward PE	31.38
Dividend	n/a
Ex-Dividend Date	n/a

Volume	149,050
Average Volume	98,178
Open	56.45
Previous Close	56.25
Day's Range	56.25 - 59.50
52-Week Range	25.30 - 71.25
Beta	0.55
RSI	69.57
Earnings Date	Mar 26, 2026

About HKG:6609

Shanghai HeartCare Medical Technology Corporation Limited engages in the research and development, manufacture, and sale of neuro-interventional medical devices in Mainland China and internationally. It offers ischemic stroke thrombectomy devices, such as Captor Thrombectomy Stent, a thrombectomy stent retriever; aspiration catheter and pump; intracranial stenosis treatment devices, including intracranial drug-eluting balloon stent, embolization protection system, carotid artery stent, and intracranial balloon dilatation catheter and carotid ar...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2016
• Employees: 368
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 6609

Financial Performance

Financial numbers in CNY